Physician profile
Johnathan E Sawyer
NPI 1821108630
$1,649.08
in general payments reported to CMS, 2019-2025
19 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $604 · 2022: $459 · 2023: $193 · 2024: $248 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $323.89 | 2021-2025 | Airsupra, Farxiga |
| Abbvie INC. | $226.32 | 2021-2025 | |
| Lilly USA, LLC | $192.18 | 2021-2024 | Zepbound, Jardiance, Mounjaro |
| Amgen INC. | $166.23 | 2021-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $155.02 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $127.79 | 2021-2022 | |
| Lundbeck LLC | $95.34 | 2023-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $62.75 | 2021 | |
| Pfizer INC. | $51.01 | 2021-2024 | |
| Horizon Therapeutics Plc | $44.63 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.47 | 2021-2025 | Trintellix |
| Novo Nordisk INC | $38.15 | 2022-2024 | Rybelsus, Ozempic |
| Esperion Therapeutics, INC. | $30.13 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.09 | 2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $16.16 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Snap Diagnostics LLC | $15.34 | 2024 | Snap Diagnostics Study |
| Otsuka America Pharmaceutical, INC. | $14.45 | 2024 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $13.29 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.